8-KEarnings & ResultsLeadership ChangesExhibits & Filings

Elevance Health, Inc. 8-K Report, Financial Results (Jan 31, 2018)

Filed January 31, 2018For Securities:ELV

Summary

Elevance Health, Inc. (formerly Anthem, Inc.) filed an 8-K on January 31, 2018, to report its fourth quarter and full-year financial results for 2017. While the specific financial figures are detailed in an attached press release (Exhibit 99.1), this filing serves to officially disseminate that information. Investors should note that the press release itself contains a comprehensive overview of the company's performance, including revenue, earnings, and any guidance provided for the upcoming period. Additionally, the 8-K announced a significant corporate governance update: the election of Bahija Jallal as an independent director to the Board, effective February 1, 2018. Ms. Jallal was also appointed to the Compensation and Governance Committees, indicating her immediate involvement in key board functions. This appointment is an important signal to investors regarding the composition and expertise of the company's leadership and its commitment to effective governance.

Key Highlights

  • 1Filing disseminates financial results for the fourth quarter and full year ended December 31, 2017, via an attached press release.
  • 2Bahija Jallal elected as an independent director to the Board of Directors, effective February 1, 2018.
  • 3Ms. Jallal's term as director will expire at the 2019 annual meeting of shareholders.
  • 4Ms. Jallal appointed to serve on the Compensation and Governance Committees of the Board.
  • 5Information furnished in this 8-K is not deemed 'filed' for Section 18 purposes and generally not incorporated by reference into other SEC filings unless expressly stated.
  • 6The company's name was Anthem, Inc. at the time of this filing.

Frequently Asked Questions

The 8-K itself does not contain the detailed financial results but references a press release (Exhibit 99.1) issued on January 31, 2018, which reports the fourth quarter and full-year financial results for the period ended December 31, 2017. Investors should refer to Exhibit 99.1 for specific financial figures, performance metrics, and any forward-looking guidance.

Bahija Jallal has been elected as an independent director to the Board of Directors and appointed to the Compensation and Governance Committees. Her election adds new expertise and perspective to the board's oversight functions. Her participation in key committees is an indicator of her role in strategic decision-making and corporate governance.

The disclaimer indicates that information furnished in this 8-K, including the press releases, is not legally considered 'filed' under Section 18 of the Securities Exchange Act of 1934. This means that statements made within these furnished documents do not carry the same legal liability as information that is formally filed. It also means this information won't automatically be incorporated by reference into future SEC filings unless explicitly stated.

At the time of this filing on January 31, 2018, the company's name was Anthem, Inc. It has since rebranded to Elevance Health, Inc.